In vivo fluorescence imaging of the transport of charged chlorine6 conjugates in a rat orthotopic prostate tumour

SummaryPolymeric drug conjugates are used in cancer therapy and, varying their molecular size and charge, will affect their in vivo transport and extravasation in tumours. Partitioning between tumour vasculature and tumour tissue will be of particular significance in the case of photosensitizer conjugates used in photodynamic therapy, where this partitioning can lead to different therapeutic effects. Poly-l-lysine chlorin e6 conjugates (derived from polymers of average Mr 5000 and 25 000) were prepared both in a cationic state and by poly-succinylation in an anionic state. A fluorescence scanning laser microscope was used to follow the pharmacokinetics of these conjugates in vivo in an orthotopic rat prostate cancer model obtained with MatLyLu cells. Fluorescence was excited with the 454–528 nm group of lines of an argon laser and a 570 nm long pass filter used to isolate the emission. Results showed that the conjugates initially bound to the walls of the vasculature, before extravasating into the tissue, and eventually increasing in fluorescence. The anionic conjugates produced tissue fluorescence faster than the cationic ones, and surprisingly, the larger Mr conjugates produced tissue fluorescence faster than the smaller ones with the same charge. These results are consistent with differences in aggregation state between conjugates.

[1]  E. Larson,et al.  Artificial reductant enhancement of the Lowry method for protein determination. , 1986, Analytical biochemistry.

[2]  R. Webb,et al.  In vivo confocal scanning laser microscopy of human skin: melanin provides strong contrast. , 1995, The Journal of investigative dermatology.

[3]  R K Jain,et al.  Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. , 1997, The American journal of pathology.

[4]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[5]  B. Ortel,et al.  Photodynamic therapy with systemic administration of photosensitizers in dermatology. , 1996, Journal of photochemistry and photobiology. B, Biology.

[6]  Michael R Hamblin,et al.  On the mechanism of the tumour-localising effect in photodynamic therapy. , 1994, Journal of photochemistry and photobiology. B, Biology.

[7]  R. Boyle,et al.  Structure and Biodistribution Relationships of Photodynamic Sensitizers * , 1996, Photochemistry and photobiology.

[8]  N. J. McNally,et al.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.

[9]  N. Simionescu,et al.  Anionized and cationized hemeundecapeptides as probes for cell surface charge and permeability studies: differentiated labeling of endothelial plasmalemmal vesicles , 1985, The Journal of cell biology.

[10]  G. Bottiroli,et al.  EQUILIBRIUM AMONG HEMATOPORPHYRIN DERIVATIVE COMPONENTSs—II. EFFECT OF ESTERASE ACTIVITY , 1990, Photochemistry and photobiology.

[11]  Michael R Hamblin,et al.  Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. , 1997, British Journal of Cancer.

[12]  W R Greco,et al.  An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. , 1997, Cancer research.

[13]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[14]  M W Berns,et al.  Photochemotherapy of hypervascular dermal lesions: A possible alternative to photothermal therapy? , 1990, Lasers in surgery and medicine.

[15]  J. Kopeček Targetable Polymeric Anticancer Drugs , 1991, Annals of the New York Academy of Sciences.

[16]  A. Richter,et al.  MODIFIED POLYVINYL ALCOHOL‐BENZOPORPHYRIN DERIVATIVE CONJUGATES AS PHOTOTOXIC AGENTS , 1993, Photochemistry and photobiology.

[17]  S. L. Rakestraw,et al.  Preparation and characterization of immunoconjugates for antibody-targeted photolysis. , 1990, Bioconjugate chemistry.

[18]  R. Jain,et al.  Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed. , 1984, The American journal of physiology.

[19]  N. Simionescu,et al.  Functions of the endothelial cell surface. , 1986, Annual review of physiology.

[20]  G. Jori,et al.  Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies. , 1990, British Journal of Cancer.

[21]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[22]  R K Jain,et al.  Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. , 1990, Journal of the National Cancer Institute.

[23]  J. Frisoli,et al.  Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. , 1993, Cancer research.

[24]  T. Hasan,et al.  Photoimmunotherapy of human ovarian carcinoma cells ex vivo. , 1991, Cancer research.

[25]  A. Baldwin,et al.  Endothelial Transport of Anionized and Cationized Ferritin in the Rabbit Thoracic Aorta and Vasa Vasorum , 1984, Arteriosclerosis.

[26]  H. Dvorak,et al.  Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.

[27]  G. Palade,et al.  Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.

[28]  T Hasan,et al.  Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[30]  D. Heistad,et al.  Permeability of blood-brain barrier to various sized molecules. , 1985, The American journal of physiology.

[31]  R. Jain,et al.  Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Star,et al.  In vivo fluorescence and photodynamic activity of zinc phthalocyanine administered in liposomes. , 1994, British Journal of Cancer.

[33]  E. Gilboa,et al.  An experimental model simulating local recurrence and pelvic lymph node metastasis following orthotopic induction of prostate cancer , 1994, The Prostate.

[34]  T. Dougherty,et al.  Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a. , 1993, Journal of photochemistry and photobiology. B, Biology.

[35]  Michael R Hamblin,et al.  Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins. , 1994, Journal of photochemistry and photobiology. B, Biology.

[36]  P. Gullino,et al.  Bulk transfer of fluid in the interstitial compartment of mammary tumors. , 1975, Cancer research.

[37]  S. Savolainen,et al.  T Rays vs. Terrorists: Widening the Security Spectrum , 1995, British Journal of Cancer.

[38]  Z. Hall Cancer , 1906, The Hospital.

[39]  C. Edgell,et al.  Permanent cell line expressing human factor VIII-related antigen established by hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Smith,et al.  Transcutaneous determination of tissue dihematoporphyrin ether content. A device to optimize photodynamic therapy. , 1991, Archives of dermatology.

[41]  K. Ley,et al.  Segmental differences of microvascular permeability for FITC-dextrans measured in the hamster cheek pouch. , 1986, Microvascular research.

[42]  J. Kopeček,et al.  Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery. , 1987, Cancer treatment reviews.

[43]  L. Seymour Passive tumor targeting of soluble macromolecules and drug conjugates. , 1992, Critical reviews in therapeutic drug carrier systems.

[44]  C. P. Winlove,et al.  Focal and regional variations in the composition of the glycocalyx of large vessel endothelium. , 1994, Journal of vascular research.

[45]  J. Moore Photodynamic Therapy: Basic Principles and Clinical Applications , 1993, British Journal of Cancer.

[46]  Michael R Hamblin,et al.  The Effect of Charge on Cellular Uptake and Phototoxicity of Polylysine Chlorine6Conjugates , 1997, Photochemistry and photobiology.

[47]  N. Simionescu,et al.  Differentiated microdomains on the luminal surface of the capillary endothelium. I. Preferential distribution of anionic sites , 1981, The Journal of cell biology.

[48]  H. Dvorak,et al.  The vesiculo‐vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation , 1996, Journal of leukocyte biology.

[49]  U. Boggi,et al.  Initial tumor targeting, biodistribution, and pharmacokinetic evaluation of the monoclonal antibody PAM4 in patients with pancreatic cancer. , 1995, Cancer research.

[50]  S. Vitols,et al.  Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice. , 1986, Cancer research.

[51]  R Birngruber,et al.  Vascular targeting in photodynamic occlusion of subretinal vessels. , 1994, Ophthalmology.

[52]  N. L. Krinick,et al.  A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. , 1994, Journal of biomaterials science. Polymer edition.

[53]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[54]  H. Dvorak,et al.  Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[55]  H. Dvorak,et al.  Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. , 1991, Cancer cells.

[56]  M. Wolgast,et al.  Permeability of renal capillaries. II. Transport of neutral and charged protein molecular probes. , 1987, Acta physiologica Scandinavica.

[57]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[58]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.